Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET EARLY CALL: Lower Call; Shire And Takeda Reach Deal

Wed, 25th Apr 2018 06:59

LONDON (Alliance News) - Stock prices in London are set to open lower on Wednesday after equities in the US slumped on Tuesday.

This comes amid a quiet day for economic data ahead of the European Central Bank's latest monetary policy decision on Thursday. However a number of UK blue-chip companies, including Lloyds Banking and Whitbread, are scheduled to provide updates prior to the market open.

IG says futures indicate the FTSE 100 index of large-caps to open 54.30 points lower at 7,371.10 on Wednesday. The FTSE 100 index closed up 0.4%, or 26.53 points, at 7,425.40 on Tuesday.

"As a result of last night's sharp sell-off in the US markets in Europe look set to open lower this morning with attention firmly focussed on the prospect that despite improved profits, potentially higher interest rates, as well as higher costs could be prompting investors to conclude that this could be the high-water mark for returns this year," says CMC Markets chief market analyst Michael Hewson.

In the US on Tuesday, Wall Street ended firmly in the red, with the Dow Jones Industrial Average ending down 1.7%, the S&P 500 index down 1.3% and Nasdaq Composite closing 1.7%.

Caterpillar shares showed a notable downturn after the heavy-equipment maker reported better-than-expected first quarter results but executives said the quarter would be the "high watermark for the year".

Shares in Google parent Alphabet - which reported after the market close on Monday - and in Coca-Cola also fell.

Selling pressure was also generated by a continued increase in US Treasury yields, with the yield on the benchmark ten-year note climbing above 3% for the first time since early 2014.

Back in London, FTSE 100-listed drugmaker Shire said late Tuesday it is "willing to recommend" a further revised takeover offer from Japanese firm Takeda Pharmaceutical.

The offer - the fifth approach from Takeda for Shire - values Shire shares at approximately GBP49 each, and values the company as a whole at GBP46 billion.

Shares in Shire closed up 3.4% at 3,939.00 pence on Tuesday, giving it a market capitalisation of GBP35.85 billion.

The offer comprises GBP27.26 in new Takeda shares and GBP21.75 in cash. Shire shareholders would own approximately 50% of the enlarged Takeda.

"The board has indicated to Takeda that it would be willing to recommend the revised proposal to Shire shareholders subject to satisfactory resolution of the other terms of the possible offer, including completion of reciprocal due diligence by Shire on Takeda. Accordingly, the board will engage in discussions with Takeda in relation to these terms," said Shire.

Shire said it has agreed to extend the "put-up-or-shut-up" deadline until 1700 BST on May 8, the deadline having originally been due to lapse later on Wednesday.

In Tokyo on Wednesday, Takeda shares fell on the news, down 7.0% in late trade.

This comes as equities in Asia trade lower on Wednesday. The Japanese Nikkei 225 index is down 0.3%. In China, the Shanghai Composite is down 0.3%, while the Hang Seng index in Hong Kong is down 1.0%.

In Japanese data on Tuesday, the Ministry of Economy, Trade and Industry showed the all industry activity rebounded at a slower-than-expected pace in February.

The index rose 0.4% month-on-month in February, reversing a 0.1% drop in January. However, this was just below the expected increase of 0.5%.

Headlining the corporate calendar on Wednesday are full-year results from Costa-Coffee and Premier Inn owner Whitbread, with first-quarter results from Lloyds Banking Group, and first-quarter production from gold miner Frensillo and miner Antofagasta.

There are trading statements from building materials firm CRH and housebuilder Persimmon, while drugmaker GlaxoSmithKline will release its first quarter results at 1200 BST. On AIM, online clothing retailer boohoo.com reports full-year earnings.

In a slim economic calendar on Wednesday, French consumer confidence is at 0745 BST and US MBA mortgage applications and EIA crude oil stocks are due at 1200 BST and 1530 BST, respectively.

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.